Seeking Alpha

Thermo Fisher Scientific (TMO +3.2%) moves up on upgrade to Overweight on valuation at JPMorgan....

Thermo Fisher Scientific (TMO +3.2%) moves up on upgrade to Overweight on valuation at JPMorgan. The firm says TMO's risk/reward profile has shown significant improvement, and based on comments from its call yesterday it expects the analytical equipment maker should beat current quarter guidance. The firm raises its price target to $80 from $70. View a transcript of the earnings call here: Earnings Call Transcript.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|